Asian Pacific Journal of Cancer Prevention

  • 제13권10호
  • /
  • Pages.5027-5031
  • /
  • 2012
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Expression of Survivin and Caspase 3 in Oral Squamous Cell Carcinoma and Peritumoral Tissue

  • Li, S.X. (School of Stomatology, Capital Medical University) ;
  • Chai, L. (Faculty of Dentistry, The University of Hong Kong) ;
  • Cai, Z.G. (School of Stomatology, Peking University) ;
  • Jin, L.J. (Faculty of Dentistry, The University of Hong Kong) ;
  • Chen, Y. (School of Stomatology, Peking University) ;
  • Wu, H.R. (School of Stomatology, Capital Medical University) ;
  • Sun, Z. (School of Stomatology, Capital Medical University)
  • 발행 : 2012.10.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

This study was conducted to investigate the expression of survivin and caspase 3 in oral squamous cell carcinoma and peritumoral tissue, and possible pathogenesis mechanisms. We used ELISA and western blotting to detect the protein expression levels of survivin and caspase 3 in tissue. In situ hybridization and real-time PCR were applied to assess mRNA expression levels. In this study, 13 tumor samples and 13 peritumoral tissue samples were collected from oral squamous cell carcinoma patients and 10 normal tissue samples obtained from patients without tumor. The result showed that the protein and mRNA expression of survivin in carcinoma was the highest among three types of tissue; following was that in peritumoral tissue. No difference in caspase 3 zymogen between peritumoral tissue and normal tissue could be found, while it was evidently decreased in carcinoma tissue. Activated caspase 3 was detected in normal tissue but could not be identified in peritumoral or carcinoma tissue. Our results indicate that the expression of survivin is apparently elevated in tumoral and peritumoral tissue. Expression of activated caspase 3 was not detected in tumoral tissue and the expression of caspase 3 zymogen was decreased in tumoral tissue. Our findings suggest that survivin may inhibit both synthesis and activation of caspase 3, hence inhibiting cell apoptosis and facililitating eventual development of oral squamous cell carcinoma.

키워드

참고문헌

  1. Blanc C, Deveraux QL, Krajewski S, et al (2000). Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Cancer Res, 60, 4386-90.
  2. Bursch W, Karwan A, Mayer M, et al (2008). Cell death and autophagy: cytokines, drugs, and nutritional factors. Toxicology, 254, 147-57. https://doi.org/10.1016/j.tox.2008.07.048
  3. De Maria S, Pannone G, Bufo P, et al (2009). Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma. J Cancer Res Clin Oncol, 135, 107-16. https://doi.org/10.1007/s00432-008-0433-z
  4. Fraunholz I, Rodel C, Distel L, et al (2012). High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy. Radiat Oncol, 7, 88. https://doi.org/10.1186/1748-717X-7-88
  5. Gibson S, Shillitoe EJ(2006). Analysis of apoptosis-associated genes and pathways in oral cancer cells. J Oral Pathol Med, 35, 146-54. https://doi.org/10.1111/j.1600-0714.2006.00398.x
  6. Gomes TS, Oshima CT, Segreto HR, et al (2011). The extrinsic apoptotic signaling pathway in gastric adenocarcinomas assessed by tissue microarray. Pathol Res Pract, 207, 613-7. https://doi.org/10.1016/j.prp.2011.06.010
  7. Grutter MG (2000). Caspases: key players in programmed cell death. Curr Opin Struct Biol, 10, 649-55. https://doi.org/10.1016/S0959-440X(00)00146-9
  8. Halasova E, Adamkov M, Matakova T, et al (2012). Expression of Ki-67, Bcl-2, Survivin and p53 Proteins in Patients with Pulmonary Carcinoma. Adv Exp Med Biol, 756, 15-21.
  9. Kanwar JR, Kamalapuram SK, Kanwar RK (2012). Survivin Signaling in Clinical Oncology: A Multifaceted Dragon. Med Res Rev. doi: 10.1002/med.21264.
  10. Khan Z, Tiwari RP, Mulherkar R, et al (2009). Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings. Head Neck, 31, 1039-48. https://doi.org/10.1002/hed.21071
  11. Kim WH, Yeo M, Kim MS, et al (2000). Role of caspase-3 in apoptosis of colon cancer cells induced by nonsteroidal anti-inflammatory drugs. Int J Colorectal Dis, 15, 105-11. https://doi.org/10.1007/s003840050242
  12. Ko SY, Dass CR, Nurgali K (2012). Netrin-1 in the developing enteric nervous system and colorectal cancer. Trends Mol Med, 18, 544-54. https://doi.org/10.1016/j.molmed.2012.07.001
  13. Li J, Chen P, Li XQ, et al (2012). Elevated levels of survivin and livin mRNA in bronchial aspirates as markers to support the diagnosis of lung cancer. Int J Cancer. doi: 10.1002/ijc.27757.
  14. Loncarevic S, Vignjevic S, Jovic N, et al (2012). Significance of pathohistological findings and the expression of Bcl-2 in diagnosis and treatment of oral planocellular carcinoma. Vojnosanit Pregl, 69, 314-9. https://doi.org/10.2298/VSP1204314L
  15. Malaguarnera R, Morcavallo A, Belfiore A (2012). The insulin and igf-I pathway in endocrine glands carcinogenesis. J Oncol, 2012, 635614.
  16. Mangiola A, Lama G, Giannitelli C, et al (2008). Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications. Clin Cancer Res, 13, 6970-7.
  17. McKenzie JA, Grossman D (2012). Role of the apoptotic and mitotic regulator survivin in melanoma. Anticancer Res, 32, 397-404.
  18. Preuss SF, Weinell A, Molitor M, et al (2008). Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma. Head Neck, 30, 1318-24. https://doi.org/10.1002/hed.20876
  19. Ryan BM, Konecny GE, Kahlert S, et al (2006). Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. Ann Oncol, 17, 597-604. https://doi.org/10.1093/annonc/mdj121
  20. Seol JG, Park WH, Kim ES, et al (2001). Potential role of caspase-3 and -9 in arsenic trioxide-mediated apoptosis in PCI-1 head and neck cancer cells. Int J Oncol, 18, 249-55.
  21. Sica G, Lama G, Anile C, et al (2011). Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma. Int J Oncol, 38, 41-9.
  22. Span PN, Tjan-Heijnen VC, Manders P, et al (2006). High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer. Breast Cancer Res Treat, 98, 223-30. https://doi.org/10.1007/s10549-005-9153-0
  23. Suzuki A, Hayashida M, Ito T, et al (2000). Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene, 19, 3225-34. https://doi.org/10.1038/sj.onc.1203665
  24. Suzuki A, Ito T, Kawano H, et al (2000). Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene, 19, 1346-53. https://doi.org/10.1038/sj.onc.1203429
  25. Tamm I, Kornblau SM, Segall H, et al (2000). Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res, 6, 1796-803.
  26. Waligorska-Stachura J, Jankowska A, Wasko R, et al (2012). Survivin-- prognostic tumor biomarker in human neoplasms--review. Ginekol Pol, 83, 537-40.
  27. Yu JQ, Bao W, Lei JC (2012). Emodin regulates apoptotic pathway in human liver cancer cells. Phytother Res. doi:10.1002/ptr.4703.
  28. Zhang LQ, Wang J, Jiang F, et al (2012). Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis. PLoS One, 7, e34100. https://doi.org/10.1371/journal.pone.0034100
  29. Zheng WE, Chen H, Yuan SF, et al (2012). Overexpression of ${\beta}$III-tubulin and survivin associated with drug resistance to docetaxel-based chemotherapy in advanced gastric cancer. J BUON, 17, 284-90.

피인용 문헌

  1. Targeted Silencing of Inhibitors of Apoptosis Proteins with siRNAs: A Potential Anti-cancer Strategy for Hepatocellular Carcinoma vol.14, pp.9, 2013, https://doi.org/10.7314/APJCP.2013.14.9.4943
  2. Clinicopathological and Prognostic Significance of Survivin Expression in Patients with Oral Squamous Cell Carcinoma: Evidence from a Meta-Analysis vol.10, pp.2, 2015, https://doi.org/10.1371/journal.pone.0116517
  3. An in silico Appraisal to Identify High Affinity Anti-Apoptotic Synthetic Tetrapeptide Inhibitors Targeting the Mammalian Caspase 3 Enzyme vol.15, pp.23, 2014, https://doi.org/10.7314/APJCP.2014.15.23.10137
  4. Molecular Pathology Signatures in Predicting Malignant Potentiality of Dysplastic Oral Pre-cancers vol.3, pp.2, 2015, https://doi.org/10.1007/s40362-015-0033-7
  5. Does Notch play a tumor suppressor role across diverse squamous cell carcinomas? vol.5, pp.8, 2016, https://doi.org/10.1002/cam4.731
  6. Impacts of survivin and caspase-3 on apoptosis and angiogenesis in oral cancer vol.14, pp.3, 2017, https://doi.org/10.3892/ol.2017.6626
  7. Areca nut extract demonstrated apoptosis-inducing mechanism by increased caspase-3 activities on oral squamous cell carcinoma vol.7, pp.2046-1402, 2018, https://doi.org/10.12688/f1000research.14856.2
  8. Areca nut extract demonstrated apoptosis-inducing mechanism by increased caspase-3 activities on oral squamous cell carcinoma vol.7, pp.2046-1402, 2018, https://doi.org/10.12688/f1000research.14856.1
  9. Areca nut extract demonstrated apoptosis-inducing mechanism by increased caspase-3 activities on oral squamous cell carcinoma vol.7, pp.2046-1402, 2018, https://doi.org/10.12688/f1000research.14856.3
  10. Areca nut extract demonstrated apoptosis-inducing mechanism by increased caspase-3 activities on oral squamous cell carcinoma vol.7, pp.2046-1402, 2019, https://doi.org/10.12688/f1000research.14856.4